Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.4211
-0.0168 (-3.84%)
Sep 22, 2025, 3:36 PM EDT - Market open
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $20.27 million as of September 22, 2025. Its market cap has decreased by -49.19% in one year.
Market Cap
20.27M
Enterprise Value
8.49M
1-Year Change
-49.19%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $20.27M, a decrease of -68.81%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 16.90M | -29.29% |
| Dec 31, 2024 | 23.90M | -41.28% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
| Jul 12, 2017 | 65.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.09B |
| Johnson & Johnson | 424.33B |
| AbbVie | 393.01B |
| UnitedHealth Group | 304.93B |
| Novo Nordisk | 271.64B |
| Novartis AG | 237.99B |
| Abbott Laboratories | 236.77B |
| AstraZeneca | 236.24B |